FTC Urges Pa. Judge Not To Extend Deadline For Abbvie Docs
By Kelly Knaub ( June 29, 2016, 10:54 PM EDT) -- The Federal Trade Commission on Tuesday hit back at Abbvie Inc.'s Monday assertion that the agency is bringing up "new purported discovery disputes" in a pay-for-delay suit over the testosterone treatment AndroGel, urging a Pennsylvania federal judge not to allow Abbvie to delay resolution of Abbvie's outstanding privilege challenges....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.